Transaction #26170 · Form 4 · 0001493152-25-029601
Kairos Pharma, LTD. · Stock award · COMMON STOCK
Kairos Pharma, LTD. · Transacted October 8, 2025 · Filed December 30, 2025
What does this filing report?
An SEC Form 4 filing for Kairos Pharma, LTD. records a stock award involving COMMON STOCK on October 8, 2025. The reported quantity was 171,756. The filing date is December 30, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Kairos Pharma, LTD.
- Company CIK
- 0001962011
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 171,756
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 1,311,739
- Ownership description
- Not reported
- SEC acceptance time
- Dec 30, 2025, 4:10 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Bhowmick Neil ↗
Chief Scientific Officer
CIK 0001872210
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Represents 171,756 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 171,756 RSUs are scheduled to vest on the on the first anniversary of the grant date which is October 8, 2026.
- F2
- Consists of (1) 1,135,317 shares of common stock and (2) 176,422 RSUs which remain subject to vesting.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.